Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study
Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion...
Saved in:
| Published in | PloS one Vol. 17; no. 8; p. e0270675 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
05.08.2022
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.
The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3.
At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure.
Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. |
|---|---|
| AbstractList | Background
Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.
Methods
The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000–2004), 2 (2005–2008), and 3 (2009–2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3.
Results
At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46–1.10) for CVD, 0.68 (0.34–1.34) for coronary heart disease, 0.65 (0.27–1.52) for stroke, and 0.55 (0.33–0.90) for heart failure.
Conclusion
Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. Background Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. Methods The Jackson Heart Study (JHS) enrolled 5,306 African-American adults [greater than or equal to]21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. Results At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income [greater than or equal to]$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure. Conclusion Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. The Jackson Heart Study (JHS) enrolled 5,306 African-American adults [greater than or equal to]21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income [greater than or equal to]$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure. Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. BackgroundMaintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.MethodsThe Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3.ResultsAt Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure.ConclusionLess than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.BACKGROUNDMaintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3.METHODSThe Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3.At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure.RESULTSAt Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure.Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure.CONCLUSIONLess than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. Background Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. Methods The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000–2004), 2 (2005–2008), and 3 (2009–2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. Results At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46–1.10) for CVD, 0.68 (0.34–1.34) for coronary heart disease, 0.65 (0.27–1.52) for stroke, and 0.55 (0.33–0.90) for heart failure. Conclusion Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46-1.10) for CVD, 0.68 (0.34-1.34) for coronary heart disease, 0.65 (0.27-1.52) for stroke, and 0.55 (0.33-0.90) for heart failure. Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure. |
| Audience | Academic |
| Author | Muntner, Paul Shimbo, Daichi Bress, Adam P Ogedegbe, Gbenga Hardy, Shakia T Jaeger, Byron C Colvin, Calvin L Sims, Mario Sakhuja, Swati Spruill, Tanya M Tajeu, Gabriel S O'Brien, Emily C Gaye, Bamba |
| AuthorAffiliation | 7 Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States of America Albert Einstein College of Medicine, UNITED STATES 4 INSERM, U970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France 1 Department of Health Services Administration and Policy, Temple University, Philadelphia, PA, United States of America 8 Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States of America 5 Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, Paris, France 2 Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America 10 Departments of Population Health Sciences and Neurology, Duke University School of Medicine, Durham, NC, United States of America 6 Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Wake Forest, NC, United States of America 9 Department of Medicine, Columbia University Irving Medical Center, |
| AuthorAffiliation_xml | – name: 5 Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, Paris, France – name: 7 Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States of America – name: Albert Einstein College of Medicine, UNITED STATES – name: 6 Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Wake Forest, NC, United States of America – name: 3 Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States of America – name: 4 INSERM, U970, Paris Cardiovascular Research Center, Department of Epidemiology, Paris, France – name: 1 Department of Health Services Administration and Policy, Temple University, Philadelphia, PA, United States of America – name: 9 Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States of America – name: 8 Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States of America – name: 2 Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America – name: 10 Departments of Population Health Sciences and Neurology, Duke University School of Medicine, Durham, NC, United States of America |
| Author_xml | – sequence: 1 givenname: Gabriel S orcidid: 0000-0002-9982-5250 surname: Tajeu fullname: Tajeu, Gabriel S organization: Department of Health Services Administration and Policy, Temple University, Philadelphia, PA, United States of America – sequence: 2 givenname: Calvin L surname: Colvin fullname: Colvin, Calvin L organization: Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America – sequence: 3 givenname: Shakia T surname: Hardy fullname: Hardy, Shakia T organization: Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America – sequence: 4 givenname: Adam P surname: Bress fullname: Bress, Adam P organization: Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT, United States of America – sequence: 5 givenname: Bamba surname: Gaye fullname: Gaye, Bamba organization: Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, Paris, France – sequence: 6 givenname: Byron C surname: Jaeger fullname: Jaeger, Byron C organization: Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Wake Forest, NC, United States of America – sequence: 7 givenname: Gbenga surname: Ogedegbe fullname: Ogedegbe, Gbenga organization: Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States of America – sequence: 8 givenname: Swati surname: Sakhuja fullname: Sakhuja, Swati organization: Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America – sequence: 9 givenname: Mario surname: Sims fullname: Sims, Mario organization: Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States of America – sequence: 10 givenname: Daichi surname: Shimbo fullname: Shimbo, Daichi organization: Department of Medicine, Columbia University Irving Medical Center, New York, NY, United States of America – sequence: 11 givenname: Emily C surname: O'Brien fullname: O'Brien, Emily C organization: Departments of Population Health Sciences and Neurology, Duke University School of Medicine, Durham, NC, United States of America – sequence: 12 givenname: Tanya M surname: Spruill fullname: Spruill, Tanya M organization: Department of Population Health, NYU Grossman School of Medicine, New York, NY, United States of America – sequence: 13 givenname: Paul surname: Muntner fullname: Muntner, Paul organization: Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States of America |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35930588$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk21rFDEQxxep2Af9BqKBgij0zjxsshtfCKWorRQqtvo2ZLOzd7nmNmeSPe038GOb866lJ30heZFk8pv_TGaY_WKn9z0UxXOCx4RV5O3MD6HXbrzI5jGmFRYVf1TsEcnoSFDMdu6dd4v9GGcYc1YL8aTYZVwyzOt6r_j9JcBSO-gNHKFg4zXqtEk-xCOk-xYZHVrrlzqawemAWhtBR0B-SMbPISIdozdWJ2jRT5umaAEh2pigT6hx3rdoESDGIQAyvk_Bu3foagroszbX0ffoFHRI6DIN7c3T4nGnXYRnm_2g-Pbxw9XJ6ej84tPZyfH5yAhJ00hyLXhDgHQCcyEl7ajWtGxpxUiFudS6rUqT79DUFW2kJLxhvNFAy4qJmrOD4uVad-F8VJsiRkWzFq7rktaZOFsTrdcztQh2rsON8tqqvwYfJipnbY0D1WLZiho4zmFKVpOmLBsiyqojsgJCcNZ6v4k2NHNoTS5M0G5LdPult1M18UslGedEiizweiMQ_I8BYlJzGw04p3vwwzrvCtO6WuV9-A_68O821CR3Xdm-8zmuWYmq44pQISjDq7zHD1B5tTC3uZXQ2Wzfcniz5bBqN_xKEz3EqM4uv_4_e_F9m311j52CdmkavRuS9X3cBss1aIKPMUB3V2SC1WpgbquhVgOjNgOT3V7cb9Cd0-2EsD_LCRKY |
| CitedBy_id | crossref_primary_10_1097_HCO_0000000000001040 crossref_primary_10_1001_jamacardio_2022_3357 crossref_primary_10_1016_j_clnesp_2023_12_009 |
| Cites_doi | 10.1111/jch.13515 10.1093/eurheartj/ehv633 10.1001/archinte.1993.00410050036006 10.1161/JAHA.119.012277 10.1161/HYPERTENSIONAHA.107.090290 10.1053/j.ajkd.2017.08.021 10.1161/CIRCRESAHA.118.313236 10.3109/08037051.2015.1127528 10.1161/HYPERTENSIONAHA.114.04012 10.1001/jama.2016.7050 10.1097/MLR.0000000000000467 10.1161/CIRCOUTCOMES.117.004386 10.1001/jama.2013.285122 10.1097/MBP.0000000000000379 10.1093/ajh/hpw010 10.1161/JAHA.119.013636 10.1016/j.cjca.2014.01.003 10.1257/aer.20150572 10.1016/j.amjhyper.2005.10.022 10.1056/NEJMoa1717250 10.1038/ajh.2009.191 10.1161/01.HYP.25.3.305 10.1097/HJH.0000000000001576 10.1001/jamainternmed.2017.1226 10.1016/S0140-6736(02)11911-8 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2022 Public Library of Science 2022 Tajeu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Tajeu et al 2022 Tajeu et al |
| Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Tajeu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Tajeu et al 2022 Tajeu et al |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PIMPY PQEST PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0270675 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Science in Context ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Database (1962 - current) Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) https://resources.nclive.org/materials Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agriculture Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Biological Science Collection ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic Technology Collection Technology Research Database Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Persistent Blood Pressure Control |
| EISSN | 1932-6203 |
| Editor | Santulli, Gaetano |
| Editor_xml | – sequence: 1 givenname: Gaetano surname: Santulli fullname: Santulli, Gaetano |
| ExternalDocumentID | 2699088428 oai_doaj_org_article_d09d68e509154381b44b1647f197e110 A712662300 10_1371_journal_pone_0270675 35930588 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: K24 HL125704 – fundername: NIMHD NIH HHS grantid: HHSN268201800013I – fundername: NHLBI NIH HHS grantid: HHSN268201800014I – fundername: NIDDK NIH HHS grantid: R01 DK108628 – fundername: NHLBI NIH HHS grantid: HHSN268201800012I – fundername: NHLBI NIH HHS grantid: HHSN268201800010I – fundername: NHLBI NIH HHS grantid: HHSN268201800012C – fundername: NHLBI NIH HHS grantid: HHSN268201800014C – fundername: NHLBI NIH HHS grantid: K01 HL151974 – fundername: NHLBI NIH HHS grantid: R01 HL117323 – fundername: ; grantid: HHSN268201800015I – fundername: ; grantid: HHSN268201800014I – fundername: ; grantid: HHSN268201800011I – fundername: ; grantid: 1K01HL151974-01 – fundername: ; grantid: HHSN268201800010I – fundername: ; grantid: HHSN268201800012I – fundername: ; grantid: HHSN268201800013I – fundername: ; grantid: 3R01 DK108628 S1 – fundername: ; grantid: K24 HL125704 |
| GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BBORY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF D1I D1J D1K DIK DU5 E3Z EAP EAS EBD ECM EIF EMOBN ESTFP ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ NPM O5R O5S OK1 P2P P62 PATMY PDBOC PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RIG RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM AAYXX CITATION AFPKN 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PQEST PQUKI PRINS RC3 7X8 5PM - 02 AAPBV ABPTK BBAFP KM |
| ID | FETCH-LOGICAL-c692t-95a65b1e1f6056992f2aa24d27317059aad74c4d2eb872b9915b35bae24736853 |
| IEDL.DBID | RPM |
| ISSN | 1932-6203 |
| IngestDate | Sun Sep 04 00:10:44 EDT 2022 Tue Oct 22 15:11:31 EDT 2024 Tue Sep 17 21:25:36 EDT 2024 Sat Oct 26 04:56:17 EDT 2024 Thu Oct 10 16:28:15 EDT 2024 Tue Nov 19 20:48:43 EST 2024 Tue Nov 12 22:56:27 EST 2024 Thu Aug 01 19:43:54 EDT 2024 Thu Aug 01 19:34:31 EDT 2024 Tue Aug 20 22:11:41 EDT 2024 Thu Nov 21 21:47:53 EST 2024 Sat Nov 02 12:15:34 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-95a65b1e1f6056992f2aa24d27317059aad74c4d2eb872b9915b35bae24736853 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Competing Interests: P. Muntner receives grant funding and consulting fees from Amgen, Inc, unrelated to topic in the current manuscript. The other authors report no conflicts. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. |
| ORCID | 0000-0002-9982-5250 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355196/ |
| PMID | 35930588 |
| PQID | 2699088428 |
| PQPubID | 1436336 |
| PageCount | e0270675 |
| ParticipantIDs | plos_journals_2699088428 doaj_primary_oai_doaj_org_article_d09d68e509154381b44b1647f197e110 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9355196 proquest_miscellaneous_2699702878 proquest_journals_2699088428 gale_infotracmisc_A712662300 gale_infotracacademiconefile_A712662300 gale_incontextgauss_ISR_A712662300 gale_incontextgauss_IOV_A712662300 gale_healthsolutions_A712662300 crossref_primary_10_1371_journal_pone_0270675 pubmed_primary_35930588 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-08-05 |
| PublicationDateYYYYMMDD | 2022-08-05 |
| PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | D Mozaffarian (pone.0270675.ref003) 2016; 133 NB Allen (pone.0270675.ref004) 2014; 311 SR Seals (pone.0270675.ref012) 2019; 24 JM Dinkler (pone.0270675.ref032) 2016; 29 G Currie (pone.0270675.ref022) 2018; 36 KN Kershaw (pone.0270675.ref028) 2017; 177 P Muntner (pone.0270675.ref007) 2020 MV Rocco (pone.0270675.ref024) 2018; 71 U.S. Department of Health and Human Services (pone.0270675.ref018) 2020 A Shahu (pone.0270675.ref025) 2019; 8 A Sumarsono (pone.0270675.ref034) 2020 JJ Sim (pone.0270675.ref029) 2014; 30 DC Goff (pone.0270675.ref014) 2014; 129 PA Meredith (pone.0270675.ref017) 2016; 25 A Benetos (pone.0270675.ref021) 2019; 124 G Mancia (pone.0270675.ref015) 2016; 37 V Fontil (pone.0270675.ref030) 2018; 11 SS Yoon (pone.0270675.ref008) 2015; 65 E Keku (pone.0270675.ref013) 2005; 15 JD Williamson (pone.0270675.ref023) 2016; 315 J Chen (pone.0270675.ref033) 2016; 54 Q Gu (pone.0270675.ref005) 2010; 23 JD Williamson (pone.0270675.ref020) 2020 AM Borzecki (pone.0270675.ref019) 2006; 19 RG Victor (pone.0270675.ref031) 2018; 378 R Chetty (pone.0270675.ref027) 2016; 106 DE Anstey (pone.0270675.ref026) 2019; 8 VL Burt (pone.0270675.ref009) 1995; 25 HA Taylor (pone.0270675.ref011) 2005; 15 G Mancia (pone.0270675.ref016) 2007; 50 J Stamler (pone.0270675.ref002) 1993; 153 PK Whelton (pone.0270675.ref006) 2018; 138 S Lewington (pone.0270675.ref001) 2002; 360 CB Bowling (pone.0270675.ref010) 2019; 21 |
| References_xml | – volume: 21 start-page: 451 issue: 4 year: 2019 ident: pone.0270675.ref010 article-title: Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT publication-title: J Clin Hypertens (Greenwich). doi: 10.1111/jch.13515 contributor: fullname: CB Bowling – volume: 37 start-page: 955 issue: 12 year: 2016 ident: pone.0270675.ref015 article-title: Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv633 contributor: fullname: G Mancia – volume: 153 start-page: 598 issue: 5 year: 1993 ident: pone.0270675.ref002 article-title: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data publication-title: Archives of internal medicine doi: 10.1001/archinte.1993.00410050036006 contributor: fullname: J Stamler – year: 2020 ident: pone.0270675.ref020 article-title: Blood Pressure Control in Older Adults: Toward a More Personalized Medicine Approach. publication-title: J Am Geriatr Soc. contributor: fullname: JD Williamson – volume: 8 start-page: e012277 issue: 15 year: 2019 ident: pone.0270675.ref025 article-title: Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT. publication-title: J Am Heart Assoc. doi: 10.1161/JAHA.119.012277 contributor: fullname: A Shahu – volume: 50 start-page: 299 issue: 2 year: 2007 ident: pone.0270675.ref016 article-title: Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study publication-title: Hypertension. Aug doi: 10.1161/HYPERTENSIONAHA.107.090290 contributor: fullname: G Mancia – volume: 71 start-page: 352 issue: 3 year: 2018 ident: pone.0270675.ref024 article-title: Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2017.08.021 contributor: fullname: MV Rocco – volume: 124 start-page: 1045 issue: 7 year: 2019 ident: pone.0270675.ref021 article-title: Hypertension Management in Older and Frail Older Patients. publication-title: Circ Res. doi: 10.1161/CIRCRESAHA.118.313236 contributor: fullname: A Benetos – year: 2020 ident: pone.0270675.ref018 contributor: fullname: U.S. Department of Health and Human Services – volume: 15 start-page: S6 issue: 4 year: 2005 ident: pone.0270675.ref011 article-title: Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. publication-title: Ethn Dis. Autumn contributor: fullname: HA Taylor – volume: 133 start-page: e38 issue: 4 year: 2016 ident: pone.0270675.ref003 article-title: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association publication-title: Circulation contributor: fullname: D Mozaffarian – volume: 25 start-page: 74 issue: 2 year: 2016 ident: pone.0270675.ref017 article-title: Importance of sustained and "tight" blood pressure control in patients with high cardiovascular risk publication-title: Blood Press doi: 10.3109/08037051.2015.1127528 contributor: fullname: PA Meredith – volume: 15 start-page: S6-62 issue: 4 year: 2005 ident: pone.0270675.ref013 article-title: Cardiovascular disease event classification in the Jackson Heart Study: methods and procedures. publication-title: Ethn Dis. Autumn contributor: fullname: E Keku – volume: 65 start-page: 54 issue: 1 year: 2015 ident: pone.0270675.ref008 article-title: Trends in blood pressure among adults with hypertension: United States, 2003 to 2012 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.04012 contributor: fullname: SS Yoon – year: 2020 ident: pone.0270675.ref007 article-title: Trends in Blood Pressure Control Among US Adults With Hypertension, 1999–2000 to 2017–2018 publication-title: JAMA contributor: fullname: P Muntner – volume: 315 start-page: 2673 issue: 24 year: 2016 ident: pone.0270675.ref023 article-title: Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged >/ = 75 Years: A Randomized Clinical Trial publication-title: JAMA doi: 10.1001/jama.2016.7050 contributor: fullname: JD Williamson – volume: 54 start-page: 140 issue: 2 year: 2016 ident: pone.0270675.ref033 article-title: Racial and Ethnic Disparities in Health Care Access and Utilization Under the Affordable Care Act. publication-title: Med Care. Feb doi: 10.1097/MLR.0000000000000467 contributor: fullname: J Chen – volume: 11 start-page: e004386 issue: 7 year: 2018 ident: pone.0270675.ref030 article-title: Adapting and Evaluating a Health System Intervention From Kaiser Permanente to Improve Hypertension Management and Control in a Large Network of Safety-Net Clinics. publication-title: Circ Cardiovasc Qual Outcomes. doi: 10.1161/CIRCOUTCOMES.117.004386 contributor: fullname: V Fontil – volume: 311 start-page: 490 issue: 5 year: 2014 ident: pone.0270675.ref004 article-title: Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age publication-title: JAMA. doi: 10.1001/jama.2013.285122 contributor: fullname: NB Allen – volume: 24 start-page: 130 issue: 3 year: 2019 ident: pone.0270675.ref012 article-title: Calibration of blood pressure measurements in the Jackson Heart Study publication-title: Blood Press Monit doi: 10.1097/MBP.0000000000000379 contributor: fullname: SR Seals – volume: 129 start-page: S49 issue: 25 year: 2014 ident: pone.0270675.ref014 article-title: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. publication-title: Circulation. contributor: fullname: DC Goff – volume: 29 start-page: 934 issue: 8 year: 2016 ident: pone.0270675.ref032 article-title: Does Age Matter? Association Between Usual Source of Care and Hypertension Control in the US Population: Data From NHANES 2007–2012 publication-title: Am J Hypertens doi: 10.1093/ajh/hpw010 contributor: fullname: JM Dinkler – volume: 8 start-page: e013636 issue: 15 year: 2019 ident: pone.0270675.ref026 article-title: Income Inequality and Hypertension Control. publication-title: J Am Heart Assoc. doi: 10.1161/JAHA.119.013636 contributor: fullname: DE Anstey – volume: 30 start-page: 544 issue: 5 year: 2014 ident: pone.0270675.ref029 article-title: Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience publication-title: Can J Cardiol doi: 10.1016/j.cjca.2014.01.003 contributor: fullname: JJ Sim – volume: 106 start-page: 855 issue: 4 year: 2016 ident: pone.0270675.ref027 article-title: The Effects of Exposure to Better Neighborhoods on Children: New Evidence from the Moving to Opportunity Experiment publication-title: American Economic Review doi: 10.1257/aer.20150572 contributor: fullname: R Chetty – year: 2020 ident: pone.0270675.ref034 article-title: Association of Medicaid Expansion with Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018 publication-title: Circ Cardiovasc Qual Outcomes contributor: fullname: A Sumarsono – volume: 19 start-page: 520 issue: 5 year: 2006 ident: pone.0270675.ref019 article-title: The effect of age on hypertension control and management publication-title: Am J Hypertens doi: 10.1016/j.amjhyper.2005.10.022 contributor: fullname: AM Borzecki – volume: 378 start-page: 1291 issue: 14 year: 2018 ident: pone.0270675.ref031 article-title: A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops publication-title: N Engl J Med doi: 10.1056/NEJMoa1717250 contributor: fullname: RG Victor – volume: 23 start-page: 38 issue: 1 year: 2010 ident: pone.0270675.ref005 article-title: Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension publication-title: Am J Hypertens doi: 10.1038/ajh.2009.191 contributor: fullname: Q Gu – volume: 25 start-page: 305 issue: 3 year: 1995 ident: pone.0270675.ref009 article-title: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991 publication-title: Hypertension doi: 10.1161/01.HYP.25.3.305 contributor: fullname: VL Burt – volume: 36 start-page: 234 issue: 2 year: 2018 ident: pone.0270675.ref022 article-title: Blood pressure targets in the elderly publication-title: J Hypertens. Feb doi: 10.1097/HJH.0000000000001576 contributor: fullname: G Currie – volume: 177 start-page: 996 issue: 7 year: 2017 ident: pone.0270675.ref028 article-title: Association of Changes in Neighborhood-Level Racial Residential Segregation With Changes in Blood Pressure Among Black Adults: The CARDIA Study. publication-title: JAMA Intern Med. doi: 10.1001/jamainternmed.2017.1226 contributor: fullname: KN Kershaw – volume: 360 start-page: 1903 issue: 9349 year: 2002 ident: pone.0270675.ref001 article-title: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies publication-title: Lancet doi: 10.1016/S0140-6736(02)11911-8 contributor: fullname: S Lewington – volume: 138 start-page: e426 issue: 17 year: 2018 ident: pone.0270675.ref006 article-title: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines publication-title: Circulation. contributor: fullname: PK Whelton |
| SSID | ssj0053866 |
| Score | 2.4774787 |
| Snippet | Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking... Background Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking... BackgroundMaintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking... Background Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking... |
| SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | e0270675 |
| SubjectTerms | Adult African Americans Age Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Antihypertensive drugs Antihypertensives Blood pressure Blood Pressure - physiology Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - etiology Care and treatment Cholesterol Complications and side effects Congestive heart failure Coronary artery disease Coronary heart disease Diabetes mellitus Dosage and administration Drugs Female Health aspects Health risks Heart diseases Heart failure Heart Failure - epidemiology High density lipoprotein Humans Hypertension Hypertension - complications Hypertension - drug therapy Hypertension - epidemiology Longitudinal Studies Medical personnel Medicine and Health Sciences Minority & ethnic groups Multivariable control People and places Population Prevalence Prevention Psychological aspects Regulation Risk analysis Risk Factors Stroke |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggylcXChiEBEhNWzv-WHMriGrhABJQ1JtlJ05BQsmqSQ78A342M7Y3alAlOHDc9Wy0mXm2Z5I3z4Q8U1p40fCmqDWrCqFLXhjBQgEZEnN1Azm-iyzfD2p9Kt6fybNLR30hJyzJAyfHHdZHplargPuaRDkqL4RHDayGGR1Ybq464ttiKq3BMIuVyo1ypWaHOS4Hm64NB1CIYZo824iiXv-0Ki82P7r-qpTzT-bkpa3o5Ca5kXNIepz--w65FtpbZCfP0p6-yFLSL2-TX6jQ5GJf0T5FFjnN5-vsU9fWtJqRUWl-WUO7cQAcwpVcjl2oKT6vpRt8uAawaAcaCe80smjHi0Az4_0VBdjR3LdP1zCLBopMxZ93yOnJ2y9v1kU-e6GolOFDYaRT0rPAGqh3lDG84c5xUUO2gwI8xrlaiwo-B7_S3EOWKX0pvQsc4q0gB7hLFi14e5fQABmo8M5AoSUEAGZVlUFAXeO8DKrUckmKbSDsJkls2PieTUNpkjxqMXA2B25JXmO0JlsUyI5fAGxsho39G2yW5DHG2qZu02ma22PNIGWBugwsnkYLFMlokYVz7sa-t-8-fv0Ho8-fZkbPs1HTAWoqlzsf4J5QfGtmuTezhKlezYZ3EZlbr_SWQ2Rgm4ASEn65RevVw0-mYbwoMuva0I3JRkOSqcHmXgL35NlSGtgOVjCiZ7CfuX4-0n7_FjXKUbYfFvf7_yNWD8h1jk0nSNSRe2QxXIzhIaSCg38UZ_1vb_FarA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZguXBBlFe3FDAICZCatnH8SHqpCmJZOIAEFPVm2YnTIqEkbJID_4CfzYzjBIIqxHHXs9FmHvY39jdjQp5KxS0vWRkVKs4jrhIWZTx2ESCk2BQlYHzjWb7v5fqUvzsTZ2HDrQ20ynFO9BN1Uee4R37AZIaUHEDLx833CG-NwtPVcIXGVXItZkoipS9dvRlnYohlKUO5XKLig2Cd_aau3D6kYwiWZ8uR79o_zc2L5lvdXgY8_-ZP_rEgrW6SGwFJ0pPB9Fvkiqtuka0Qqy19HhpKv7hNfmKfJuOri_YocslpuGVnj5qqoPmMkkrDkQ2t-w40A08ywYKuoLhrSxvcYgPnqDrqae_Uc2n7jaOB935EwfloqN6na4iljiJf8ccdcrp6_fnVOgo3MES5zFgXZcJIYWMXl5D1gAFYyYxhvADMg214MmMKxXP47GyqmAWsKWwirHEMrC4BCdwliwq0vU2oAxzKrckg3eIc3CbNE8chuzFWOJkosSTRaAjdDI02tD9tU5CgDBrVaDgdDLckL9Fakyy2yfZf1JtzHaJOF4dZIVOHoEhgLzPLucUGamWcKQfAZ0keoa31UHM6Bbs-UTEAF8jOQOKJl8BWGRVycc5N37b67Ycv_yH06eNM6FkQKmvwmtyE-gd4J2zBNZPcnUlCwOez4W30zFErrf4dGvDL0VsvH348DeNDkV9XubofZBRATQUy9wbnnjSbiAwWhRRG1MztZ6qfj1RfL3yncmzeD1P8zr__1n1ynWFRCRJxxC5ZdJvePQCo19mHPp5_AWaRVBE priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1di9QwFA3r-OKLuH7t6KpRBBW2wzZNm6kgsorLKKigjuxbSdp0V1jacdqC-w_82Z6bZoqVEfZxJrcZ5n4k5zb3njD2NFHSyFKUQaHCPJAqEkEqQxsAIYW6KIHxtavy_ZQslvLDSXyywzZ3tnoFNltTO7pPark-n_36efEaAf_K3dqgws1Ds1Vd2RnSLALBV9hVgb2Rirw-yuFcAdHtTi8JtQSJOIx8M93_ZhltVo7Tf1i5J6vzutkGS_-trvxruzq-wa57nMmPesfYZTu2usl2fSQ3_Lmnm35xi_0mFifteo8OOFWac38HzwHXVcHzUcEq9wc6vO5a-Cpm0t6-tuD0Tpev6AUcXKdquSuK567Stltb7qviX3K4Jve9_XyBSGs5VTNe3GbL43ff3i4Cfz9DkCepaIM01klsQhuWyImSNBWl0FrIAoiISHpSrQslc3y2Zq6EARKNTRQbbQV8IgFOuMMmFbS9x7gFSpVGp0jGpIRTzfPISuQ-2sQ2iVQ8ZcHGENmqp-HI3FmcQvrSazQjw2XecFP2hqw1yBKJtvuiXp9mPiaz4jAtkrklyBQT05mR0hC9WhmmygIWTdkjsnXWd6QOS0F2pELAGuRukHjiJIhIo6JKnVPdNU32_vP3Swh9_TISeuaFyhpek2vfHYH_RARdI8n9kSSWg3w0vEeeudFKkwlYBlsJ0kw8ufHW7cOPh2GalKrvKlt3vYwCEFWQuds796DZKE6xZcwxokZuP1L9eKT6ceZ4zInaHxvAvUv87n12TVDfCdXqxPts0q47-wBosDUPXYD_AfOcXcA priority: 102 providerName: Scholars Portal |
| Title | Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/35930588 https://www.proquest.com/docview/2699088428 https://www.proquest.com/docview/2699702878 https://pubmed.ncbi.nlm.nih.gov/PMC9355196 https://doaj.org/article/d09d68e509154381b44b1647f197e110 http://dx.doi.org/10.1371/journal.pone.0270675 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEF21QUK9IMpXAyUsCAmQ6qS2196YW1s1BKSWqlCUm7Vrr0ul1o4S58A_4GfzZr0OGPWAuFhKdmwlOzPeN-s3z4y9jqXQoggKL5d-5gkZBl4ifOMBIfkqL4DxlWX5nsbTC_FpFs02WNT2wljSfqavhuX1zbC8-m65lfObbNTyxEZnJ0ekCY7IGW2yTSy_bYne3H6RwHHseuRC6Y-cS4bzqjRD1GCEkLfY3TBKEOn2fSu_lyOr2r--N_fm19XyNuD5N3_yjwVpcp_dc0iSHzS_eJttmPIB23a5uuRvnaD0u4fsJ-k0KdtdtMeJS87dW3b2uCpznnUoqdw9suHVqkY04krKedDknHZt-Zy22BAcZc0t7Z1bLu1qYbjjvb_nCD7uuvf5FLlUc-Ir_njELibHX4-mnnsDg5fFSVB7SaTiSPvGL1D1xEkSFIFSgciBeUiGJ1EqlyLDZ6PHMtDAmpEOI61MAK_HQAKPWa_ExO8wboBDhVYJyi0hEDbjLDQC1Y3SkYlDGfWZ1zoinTdCG6l92iZRoDQzmpIPU-fDPjskb61tSSbbflEtLlMXLGm-n-Tx2BAoikjLTAuhSUCt8BNpAHz67AX5Om16TtfJnh5IH8AF1RksXlkLksooiYtzqVbLZfrx87d_MPpy3jF644yKClGTKdf_gP9EElwdy92OJRI-6wzvUGS2s7JMA3gGiwUKSZzZRuvtwy_Xw3RR4teVplo1NhJQU8LmSRPc65ltU6XPZCfsO1PfHUHiWqVyl6hP__vMZ2wroH4T4uhEu6xXL1bmOVBgrQfI_ZnEcXzk03HyYcDuHB6fnp0P7L4KjidiPLD3hl8AkWMG |
| link.rule.ids | 230,314,727,780,784,864,885,2102,2221,12056,12223,12765,21388,24318,27924,27925,31719,31720,33266,33267,33373,33374,33744,33745,43310,43579,43600,43805,53791,53793,73745,74014,74035,74302 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwELVge4ALonx1oVCDkACpaYnjjw0X1KJWWygLKi3qzbITpyChJGySA_-An82M4ywEVYjjrmejjWfGfmM_PxPyVCpuecGKKFdxFnGVsCjlsYsAIcUmLwDjG8_yXcj5GX97Ls7DglsTaJXDmOgH6rzKcI18l8kUKTmAll_X3yO8NQp3V8MVGlfJGiqniwlZ2z9YfDwZxmLIZinDgblExbvBPzt1VbodKMgQLo8mJK_bvxqdJ_W3qrkMev7NoPxjSjq8SW4ELEn3euevkyuuvEXWQ7Y29HmQlH5xm_xEpSbjzxdtU2ST03DPzjY1ZU6zESmVhk0bWnUt9A08yQQfupziui2tcZENwqNsqSe-U8-m7ZaOBub7KwrhR8P5fTqHbGopMhZ_3CFnhwenb-ZRuIMhymTK2igVRgobu7iAugdcwApmDOM5oB4U4kmNyRXP4LOzM8UsoE1hE2GNY-B3CVjgLpmU0NsbhDpAotyaFAouziFwZlniONQ3xgonEyWmJBocoeteakP7_TYFJUrfoxodp4PjpmQfvbWyRaFs_0W1vNAh73T-Ms3lzCEsEqhmZjm3KKFWxKlyAH2mZAt9rftTp6t013sqBugC9RlYPPEWKJZRIhvnwnRNo48-fP4Po08nI6NnwaioIGoyE05AwDuhCNfIcnNkCSmfjZo3MDKHXmn07-SAXw7Rennz41UzPhQZdqWrut5GAdhUYHOvD-5VzyYihWlhBi1qFPajrh-3lF-_eK1ylO-HQf7-v__WFrk2P31_rI-PFu8ekOsMj5ggLUdskkm77NxDAH6tfRSy-xcnm1hi |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegkxAviPG1wmAGIQHSsi6OYze8oA1WdYDKNBjam2UnzkBCSWiSB_4D_mzuHCcQNCEeW1-j5j7s39m_OxPyVEhueM7yIJNhGnAZsSDhoQ0AIYU6ywHja8fyXYnlGX97Hp97_lPtaZX9nOgm6qxMcY98xkSClBxAy7Pc0yJO3ixeVd8DvEEKT1r9dRpXyQasivtsQjYOj1Ynp_28DJEthC-ei2Q487baq8rC7kFyhtB5tDi5Hv7DTD2pvpX1ZTD0bzblH8vT4ia54XElPegcYZNcscUtsukjt6bPfXvpF7fJT-zapF2t0S5FZjn1d-7sUl1kNB0RVKk_wKFl24Ce4Ena29NmFPdwaYUbbuAqRUMdCZ46Zm27ttSz4F9ScEXqa_npEiKroche_HGHnC2OPr1eBv4-hiAVCWuCJNYiNqENc8iBwBwsZ1ozngECwqY8idaZ5Cl8tmYumQHkGZsoNtoy8AEBuOAumRSg7S1CLaBSbnQCyRfn4ETzNLIcch1tYisiGU9J0BtCVV3bDeXO3iSkK51GFRpOecNNySFaa5DFptnui3J9oXwMqmw_ycTcIkSKsbOZ4dxgO7U8TKQFGDQlO2hr1VWgDqGvDmQIMAZyNZB44iSwcUaBLnih27pWxx8-_4fQx9OR0DMvlJfgNan21RDwTtiQayS5PZKE8E9Hw1vomb1WavU7UOCXvbdePvx4GMaHItuusGXbyUgAnhJk7nXOPWg2ihNYIuYwIkduP1L9eKT4-sX1LcdW_jDh3__339oh1yCw1fvj1bsH5DrDahNk6MTbZNKsW_sQMGBjHvng_gVWlFyP |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence%2C+risk+factors%2C+and+cardiovascular+disease+outcomes+associated+with+persistent+blood+pressure+control%3A+The+Jackson+Heart+Study&rft.jtitle=PloS+one&rft.au=Tajeu%2C+Gabriel+S&rft.au=Colvin%2C+Calvin+L&rft.au=Hardy%2C+Shakia+T&rft.au=Bress%2C+Adam+P&rft.date=2022-08-05&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=8&rft.spage=e0270675&rft_id=info:doi/10.1371%2Fjournal.pone.0270675&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |